Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05A ANTIPSYCHOTICS
N05AH Diazepines, oxazepines, thiazepines and oxepines
N05AH05 Asenapine
D02995 Asenapine maleate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Antipsychotics
2nd Generation/Atypical
Asenapine
D02995 Asenapine maleate (JAN/USAN)
Bipolar Agents
Bipolar Agents, Other
Asenapine
D02995 Asenapine maleate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
117 Psychotropics
1179 Others
D02995 Asenapine maleate (JAN/USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG03100 Asenapine
D02995 Asenapine maleate
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG03100 Asenapine
D02995 Asenapine maleate
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG03100 Asenapine
D02995 Asenapine maleate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D02995 Asenapine maleate (JAN/USAN) <JP/US>
Serotonin
HTR1A
D02995 Asenapine maleate (JAN/USAN) <JP/US>
HTR2A
D02995 Asenapine maleate (JAN/USAN) <JP/US>
HTR2C
D02995 Asenapine maleate (JAN/USAN) <JP/US>
HTR6
D02995 Asenapine maleate (JAN/USAN) <JP/US>
HTR7
D02995 Asenapine maleate (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02995
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02995
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02995
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02995
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02995
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG03100 Asenapine
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG03100 Asenapine
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG03100 Asenapine